Financials data is unavailable for this security.
View more
Year on year Fine Foods & Pharmaceuticals NTM SpA grew revenues 21.73% from 206.85m to 251.81m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -9.50m to -3.52m.
| Gross margin | 29.88% |
|---|---|
| Net profit margin | 1.06% |
| Operating margin | 3.60% |
| Return on assets | 0.98% |
|---|---|
| Return on equity | 2.03% |
| Return on investment | 1.39% |
More ▼
Cash flow in EURView more
In 2023, Fine Foods & Pharmaceuticals NTM SpA increased its cash reserves by 85.69%, or 8.77m. Cash Flow from Investing totalled 45.89m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 18.54m in cash from operations while cash used for financing totalled 55.66m.
| Cash flow per share | 0.8909 |
|---|---|
| Price/Cash flow per share | 9.60 |
| Book value per share | 5.24 |
|---|---|
| Tangible book value per share | 4.71 |
More ▼
Balance sheet in EURView more
| Current ratio | 1.57 |
|---|---|
| Quick ratio | 0.947 |
| Total debt/total equity | 0.4814 |
|---|---|
| Total debt/total capital | 0.325 |
More ▼
Growth rates in EUR
Year on year, growth in earnings per share excluding extraordinary items increased 54.87%. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | 3.71% |
| Payout ratio (TTM) | 96.51% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 157.91 |
More ▼
